NORDHEALTH AS NK 1
Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, Denmark, Germany, and internationally. Its products include Provet Cloud, a veterinary practice management software (PMS); Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychotherapists; EasyPractice,… Read more
NORDHEALTH AS NK 1 (6E5) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, NORDHEALTH AS NK 1 (6E5) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
NORDHEALTH AS NK 1 - Net Assets Trend (None–None)
This chart illustrates how NORDHEALTH AS NK 1's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NORDHEALTH AS NK 1 (None–None)
The table below shows the annual net assets of NORDHEALTH AS NK 1 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to NORDHEALTH AS NK 1's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
NORDHEALTH AS NK 1 Competitors by Market Cap
The table below lists competitors of NORDHEALTH AS NK 1 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dongwon System
KO:014820
|
$87.86 Million |
|
AXIOS Sustainable Growth
NYSE:AXAC
|
$87.86 Million |
|
Univacco Technology
TWO:3303
|
$87.88 Million |
|
Simplex Infrastructures Limited
NSE:SIMPLEXINF
|
$87.88 Million |
|
SG Finserve Limited
NSE:SGFIN
|
$87.76 Million |
|
Lucky Cement Co
TW:1108
|
$87.74 Million |
|
Selectquote Inc
NYSE:SLQT
|
$87.72 Million |
|
Unifique Telecomunicações S.A.
SA:FIQE3
|
$87.71 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NORDHEALTH AS NK 1's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares NORDHEALTH AS NK 1's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently NORDHEALTH AS NK 1 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares NORDHEALTH AS NK 1's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NORDHEALTH AS NK 1 (6E5) | €- | N/A | N/A | $87.84 Million |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $619.47 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $379.13K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.24 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.69 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.50 Million |